<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Can Targeting Normoxemia Benefit Critically Ill Trauma Patients?

Default sub title

minute read

by MedPage Today | January 24, 2024
placeholder

Targeting normoxemia in critically ill trauma patients appeared to increase supplemental oxygen-free days in a cluster randomized stepped-wedge trial that missed on statistical significance.

Topics: Press Coverage